Epigenetic editing of
            BRCA1
            promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1080/15592294.2024.2357518

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Wanhong He & Qihan Wu et al. · 2024-05-26

Drug resistance is the primary contributor to the high mortality rate of ovarian cancer (OC). The loss of

Links

DOI PubMed

Journal

Epigenetics

Authors

Wanhong He, Haijun Zhu, Sufen Zhang, Guang Shu, Han Lei, Maonan Wang, Gang Yin, Xiaohua Ni, Qihan Wu

Funding

Supplementation with Amino Acid Rehabilitative Therapy in TBI (SmART-TBI): A Randomized Placebo-Controlled Trial to Improve Sleep Shanghai Municipal Health Commission Funds Grant 20204Y0274 Innovation-oriented Science and Technology Grant from NHC Key Lab of Reproduction Regulation Grant CX2022-03 Natural Science Foundation of Shanghai Grant 22ZR1456300

CSRD VA

I01 CX002022